Correlation Between Predictive Oncology and ResMed

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Predictive Oncology and ResMed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Predictive Oncology and ResMed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Predictive Oncology and ResMed Inc, you can compare the effects of market volatilities on Predictive Oncology and ResMed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Predictive Oncology with a short position of ResMed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Predictive Oncology and ResMed.

Diversification Opportunities for Predictive Oncology and ResMed

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Predictive and ResMed is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Predictive Oncology and ResMed Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ResMed Inc and Predictive Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Predictive Oncology are associated (or correlated) with ResMed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ResMed Inc has no effect on the direction of Predictive Oncology i.e., Predictive Oncology and ResMed go up and down completely randomly.

Pair Corralation between Predictive Oncology and ResMed

Given the investment horizon of 90 days Predictive Oncology is expected to under-perform the ResMed. In addition to that, Predictive Oncology is 4.22 times more volatile than ResMed Inc. It trades about -0.01 of its total potential returns per unit of risk. ResMed Inc is currently generating about 0.08 per unit of volatility. If you would invest  20,645  in ResMed Inc on August 31, 2024 and sell it today you would earn a total of  4,257  from holding ResMed Inc or generate 20.62% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Predictive Oncology  vs.  ResMed Inc

 Performance 
       Timeline  
Predictive Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Predictive Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.
ResMed Inc 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in ResMed Inc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound primary indicators, ResMed is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Predictive Oncology and ResMed Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Predictive Oncology and ResMed

The main advantage of trading using opposite Predictive Oncology and ResMed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Predictive Oncology position performs unexpectedly, ResMed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ResMed will offset losses from the drop in ResMed's long position.
The idea behind Predictive Oncology and ResMed Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope